ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $151,000 | -23.4% | 355,172 | +16.2% | 0.00% | – |
| Q4 2016 | $197,000 | -77.6% | 305,781 | +9.5% | 0.00% | – |
| Q3 2016 | $879,000 | +16.1% | 279,265 | +13.9% | 0.00% | – |
| Q2 2016 | $757,000 | -13.6% | 245,258 | +1.3% | 0.00% | – |
| Q1 2016 | $876,000 | -21.2% | 242,004 | +1.0% | 0.00% | -100.0% |
| Q4 2015 | $1,112,000 | -28.8% | 239,709 | -6.5% | 0.00% | 0.0% |
| Q3 2015 | $1,561,000 | -20.4% | 256,398 | +12.8% | 0.00% | 0.0% |
| Q2 2015 | $1,960,000 | +192.5% | 227,380 | +51.5% | 0.00% | – |
| Q1 2015 | $670,000 | +355.8% | 150,068 | +61.1% | 0.00% | – |
| Q4 2014 | $147,000 | -17.4% | 93,172 | 0.0% | 0.00% | – |
| Q3 2014 | $178,000 | -43.5% | 93,172 | 0.0% | 0.00% | – |
| Q2 2014 | $315,000 | +1.0% | 93,172 | 0.0% | 0.00% | – |
| Q1 2014 | $312,000 | +9.1% | 93,172 | 0.0% | 0.00% | – |
| Q4 2013 | $286,000 | -23.7% | 93,172 | -0.2% | 0.00% | – |
| Q3 2013 | $375,000 | – | 93,386 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 1,250,000 | $1,975,000 | 1.00% |
| Broadfin Capital, LLC | 3,567,624 | $5,636,000 | 0.24% |
| Abingworth LLP | 437,994 | $679,000 | 0.19% |
| GREAT POINT PARTNERS LLC | 250,000 | $395,000 | 0.19% |
| Rhenman & Partners Asset Management AB | 400,000 | $632,000 | 0.18% |
| BVF INC/IL | 559,624 | $884,000 | 0.17% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,691,857 | $2,673,000 | 0.10% |
| Perceptive Advisors | 503,156 | $795,000 | 0.07% |
| Gruss Capital Management LP | 960,000 | $1,517,000 | 0.04% |
| Spark Investment Management LLC | 103,400 | $160,000 | 0.03% |